CFColy Najah Fatou

Coly Najah Fatou

*This is an algorithmically generated author record based on publicly available information.

Coly Najah Fatou has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Correlation Between Vitamin D Levels and Dyslipidemia in Patients at Fann University Hospital

    by Kandji Matar, Thioune Mareme, Barry Kesso, Djite Moustapha, Nayo Godwin, Ndiaye Siny, Coly Fatou, Ndour Malick, Gueye-Tall Fatou, Gueye Madieye

    Vitamin D has been recognized for several decades as an important player in bone metabolism. Beyond these classic effects on mineral metabolism, it has numerous extra-osseous effects, including effects on the cardiovascular system. Indeed, several clinical studies suggest a link between vitamin D deficiency and cardiovascular mortality. The general objective is to evaluate the relationship between vitamin D levels and lipid parameters in patients at Fann University Hospital. Included in this study were 214 patients who came to the laboratory and whose vitamin D dosage was requested between December 2023 and April 2024. Lipid profile parameter dosages were performed with the Architect Ci4100 and vitamin D with Iflash 3000. Correlations between vitamin D levels and blood lipids were assessed by descriptive statistical analysis and Spearman's correlation test. The mean age of our population was 60±17 years and the sex ratio was 0.51. The distribution of patients according to the lipid profile showed that 72.42% of the subjects had a lipid abnormality with a predominance of hypo HDL-cholesterolemia (39.71%). Our study showed a positive and significant correlation between low vitamin D levels and low HDL-cholesterol levels. In contrast, no strong link was found with the levels of total cholesterol, triglycerides and LDL-cholesterol. These results highlight the importance of monitoring vitamin D levels in patients with dyslipidemia, and pave the way for future research on the potential role of vitamin D in cardiovascular risk management.

  • Open Access

    Evaluation of the Determinants of Microalbuminuria in Type 2 Diabetic Subjects

    by Djite Moustapha, Kandji Matar, Barry Oumou, Thioune Maréme, Diouf Ndane, Mbacke-Niang Ndoumbé, Ndour Malick, Coly-Gueye Fatou, Doupa Dominique, Gueye-Tall Fatou, et al.

    Diabetes is a metabolic disease characterized by chronic hyperglycemia resulting from a defect in insulin secretion and/or insulin action. When not well controlled, it leads to long-term microangiopathic complications, including diabetic nephropathy. Against this backdrop, we set out to evaluate microalbuminuria and the clinical and biological factors associated with it in subjects with type 2 diabetes. This is a prospective, descriptive study including type 2 diabetic patients well followed at the Mark Sankale Center of the Abass Ndao Hospital in Dakar. Biochemical parameters (microalbuminuria, lipid profile, glycated hemoglobin and fasting blood glucose) were measured using enzymatic techniques with the Cobas 6000/c501® system (Roche, Hitachi, Germany). XLSTAT software was used to evaluate the data, and a value of p<0.05 was considered a statistically significant difference. A total of 166 diabetic patients with a mean age of 54 ±13.9 years and a sex ratio of 0.50 were included in our study. Microalbuminuria was present in 40.36% of the study population. Among patients with unbalanced diabetes, 50.74% had positive microalbuminuria. When hypertension was associated with diabetes, microalbuminuria was positive in 61.19% of patients. In terms of dyslipidemia, hypercholesterolemia was the only abnormality significantly associated with microalbuminuria (p<0.001). Microalbuminuria is an essential parameter in the detection of diabetic nephropathy. In our study, its occurrence was associated with several abnormalities, including unbalanced diabetes, hypertension and hypercholesterolemia.

  • Open Access

    Contribution of the Triglycerides-Glucose Index (TyG) in the Assessment of Insulin Resistance in Pregnant Women During an OGTT Test

    by Thiam Souleymane, Soumah Yaya, Samba Adourahmane, Diedhiou Fatou, Dia Thorpe, Ba Ramatoulaye, Tounkara Racine, Agossou Medece, Coly Fatou, Diouf N. Dande, et al.

    The Triglyceride-Glucose (TyG) index is a marker used to assess insulin resistance which is associated with the occurrence of gestational diabetes. The aim of this study is to determine the benefit of the TyG within the diagnosis of insulin resistance in pregnant women in an orally induced hyperglycaemia test. This study was conducted at the Department of Biochemistry, at Aristide le Dantec University Hospital in collaboration with the department of gynaecology. Women with fasting blood glucose < 0.92 g/L at 12 weeks of age benefited from the OGTT 75 test following the WHO protocol. The TyG index was calculated using the formula: Ln [fasting triglyceridemia (mg/dL) × fasting blood glucose (mg/dL)]/2. Data were analysed using SPSS v.26 and a p< value of 0.05 was considered statistically significant. A total of 102 patients were included in the study with a mean age of 29± to 5.9 years. The OGTT 75 test was positive in 24 women (23.5%) with a predominance in the third trimester (19.4%). TyG values were significantly higher in women with gestational diabetes (8.76, ±0.5vs8.2±, 0.5; p1 index was 9.5 with a sensitivity and specificity of 79.2% and 71.8%, respectively. The TyG index is a better way to assess the level of insulin resistance in pregnant women than using the HOMA index, especially after the first hour of a glucose load of 75g.